Repeatability
Can the manufacturing workflow produce controlled, characterized material consistently?

The current foundation is laboratory-scale evidence. Explore each finding and the question it helps address.
Move your pointer across the structure to change the viewing angle.
Explore the original CD spectrum alongside a schematic of collagen’s three chains.
The plots are the supplied laboratory figures. The moving structure explains the concepts; it does not reproduce measured molecular motion. Raw spectral exports are not available in this viewer, so it does not calculate intensities, helix percentages or a melting temperature. Background on collagen spectroscopy ↗
Avenyx reports FTIR and CD findings supporting retained triple-helix characteristics in isolated collagen. These are structural signals from lab-scale characterization.
Type I collagen has been isolated, with receptor binding reported as validated. Performance in a specific formulation or application requires its own evaluation.
Reported yield from in-house laboratory work. Commercial throughput and manufacturing economics require validation as the process scales.
The thermal CD heatmap shows the positive band near 220 nm persisting into the mid-40s Celsius and weakening in the higher-temperature rows. Approximately 45°C is a visual estimate of where weakening begins, based on measurements at 5°C intervals. A fitted melting temperature has not been reported.
Selected figures from Avenyx’s laboratory evidence materials. Open a study for its image, reported method and interpretation.
The supplied analysis compares amide-region features with a literature reference and reports structural similarity to collagen. This plot is a sample spectrum; the literature figure is not shown as Avenyx data.
Source: Avenyx evidence materials, FTIR analysis.
| Instrument | Jasco J-1500 |
|---|---|
| Sample | Collagen I, 0.75 mg/mL |
| Wavelength range | 190–260 nm |
| Temperature ramp | 4–54°C |
| Interval | 5°C |
| Measurement solvent | 0.5% acetic acid, confirmed by instrument report |
| Scanning speed | 100 nm/min |
The source reports gradual spectral change with temperature. The temperature-resolved heatmap below provides the context for the approximate 45°C spectral-weakening threshold.
The instrument report confirms 0.5% acetic acid as the measurement solvent. The earlier presentation separately mentions 5% for redissolution; that preparation detail is not resolved by this report. The overlaid spectra above have no colour-to-temperature legend. The thermal report below supplies a temperature axis. Its heatmap supports a visual estimate of spectral weakening above approximately 45°C; a fitted transition temperature has not been reported.
The receptor and control proteins were incubated with Type I atelocollagen under native conditions. Centrifugation separated bound and unbound fractions, and the supernatant was analysed by SDS-PAGE.
The source interprets receptor depletion in the supernatant, alongside the control proteins, as evidence of binding.
Source: Avenyx evidence materials, collagen binding assay.
The supplied panel compares migration patterns across rat-tail, marine and chicken-feet Type I samples.
It provides a size-based comparison to accompany the spectroscopy and binding evidence. The image is presented without deriving a purity percentage or assigning additional band identities.
Source: Avenyx evidence materials, comparative analysis.
| Measurement solvent | 0.5% acetic acid |
|---|---|
| Sample label | 0.75 mg/mL collagen |
| Temperature programme | 4–54°C, 5°C intervals |
| Ramp setting | 10°C/min; Halt mode |
| Acquisition range | 260–190 nm |
| Data pitch | 0.1 nm · 701 points |
| Bandwidth / D.I.T. | 1 nm / 4 seconds |
| Baseline correction | None, as recorded |
| Accumulations | 1 |
The positive CD band near 220 nm remains prominent into the mid-40s Celsius, then weakens toward the top of the heatmap. This supports an approximate onset of spectral weakening above 45°C.
Visual interpretation · 5°C temperature steps. The approximate threshold is not a fitted melting temperature or a guaranteed operating limit.
Can the manufacturing workflow produce controlled, characterized material consistently?
How does the material perform in the models and formulations customers actually use?
What documentation, process controls and applicable approvals are required for supply?